Assignee
EPIZYME INC
US·151 granted patents·169 pending applications·2,247 citations·filing 2012–2025
Top patents by PatentIndex Score
320 records- 0199US9475776B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Oct 25, 2016·32 cites·9 claims
- 0299US9365519B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Jun 14, 2016·34 cites·39 claims
- 0399US9206157B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2015·Granted Dec 8, 2015·28 cites·14 claims
- 0499US9120757B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 1, 2015·45 cites·36 claims
- 0599US9023883B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 5, 2015·46 cites·20 claims
- 0699US8993555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 31, 2015·50 cites·4 claims
- 0799US8962620B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Feb 24, 2015·31 cites·10 claims
- 0899US8598167B1Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Dec 3, 2013·34 cites·12 claims
- 0998US9943504B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Apr 17, 2018·14 cites·17 claims
- 1098US9675614B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jun 13, 2017·17 cites·23 claims
- 1198US9630961B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Apr 25, 2017·21 cites·24 claims
- 1298US9604930B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 28, 2017·21 cites·35 claims
- 1398US9549931B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 24, 2017·39 cites·21 claims
- 1498US9532992B2Substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 3, 2017·32 cites·25 claims
- 1598US9522152B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Dec 20, 2016·32 cites·8 claims
- 1698US9394258B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 19, 2016·39 cites·13 claims
- 1798US9365527B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jun 14, 2016·35 cites·33 claims
- 1898US9346802B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·32 claims
- 1998US9133189B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 15, 2015·45 cites·20 claims
- 2098US9090562B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jul 28, 2015·51 cites·20 claims
- 2198US8940726B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jan 27, 2015·47 cites·22 claims
- 2298US8906900B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 9, 2014·44 cites·18 claims
- 2398US8765732B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2012·Granted Jul 1, 2014·66 cites·19 claims
- 2497US11642349B2Method for treating cancerEPIZYME INC·Filed 2020·Granted May 9, 2023·4 cites·11 claims
- 2597US11491163B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2020·Granted Nov 8, 2022·6 cites·10 claims
- 2697US11370781B2Combination therapy for treating cancerEPIZYME INC·Filed 2020·Granted Jun 28, 2022·4 cites·20 claims
- 2797US10118931B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Nov 6, 2018·19 cites·4 claims
- 2897US9765035B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 19, 2017·15 cites·14 claims
- 2997US9718816B21-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Aug 1, 2017·25 cites·28 claims
- 3097US9440950B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Sep 13, 2016·34 cites·16 claims
- 3197US9394283B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2013·Granted Jul 19, 2016·27 cites·25 claims
- 3297US9365555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jun 14, 2016·37 cites·18 claims
- 3397US9334527B2Inhibitors of human EZH2, and methods of use thereofEPIZYME INC·Filed 2014·Granted May 10, 2016·39 cites·13 claims
- 3497US9089575B2Substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jul 28, 2015·19 cites·16 claims
- 3597US9045477B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted Jun 2, 2015·19 cites·17 claims
- 3697US9045455B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jun 2, 2015·46 cites·20 claims
- 3797US9006242B2Substituted benzene compoundsEPIZYME INC·Filed 2013·Granted Apr 14, 2015·38 cites·18 claims
- 3896US11951109B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2021·Granted Apr 9, 2024·4 cites·14 claims
- 3996US11642348B2Substituted benzene compoundsEPIZYME INC·Filed 2020·Granted May 9, 2023·4 cites·12 claims
- 4096US11052093B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2019·Granted Jul 6, 2021·7 cites·20 claims
- 4196US10946024B2Method for treating cancerEPIZYME INC·Filed 2019·Granted Mar 16, 2021·7 cites·11 claims
- 4296US10787440B2Combination therapy for treating cancerEPIZYME INC·Filed 2019·Granted Sep 29, 2020·8 cites·20 claims
- 4396US10493076B2Method for treating cancerEPIZYME INC·Filed 2016·Granted Dec 3, 2019·7 cites·22 claims
- 4496US10369155B2Method for treating cancerEPIZYME INC·Filed 2017·Granted Aug 6, 2019·8 cites·20 claims
- 4596US10301290B2Combination therapy for treating cancerEPIZYME INC·Filed 2013·Granted May 28, 2019·13 cites·9 claims
- 4696US10155002B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Dec 18, 2018·16 cites·29 claims
- 4796US9889138B2Method for treating cancerEPIZYME INC·Filed 2016·Granted Feb 13, 2018·10 cites·35 claims
- 4896US9872862B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2016·Granted Jan 23, 2018·14 cites·17 claims
- 4996US9868703B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jan 16, 2018·15 cites·2 claims
- 5096US9856267B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jan 2, 2018·14 cites·4 claims
Showing the top 50 of 320 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when EPIZYME INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →